These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16625699)

  • 41. Analysis of CCR5 and SDF-1 genetic variants and HIV infection in Indian population.
    Gupta A; Padh H
    Int J Immunogenet; 2015 Aug; 42(4):270-8. PubMed ID: 26096543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Ground truth" for selection on CCR5-Delta32.
    Hedrick PW; Verrelli BC
    Trends Genet; 2006 Jun; 22(6):293-6. PubMed ID: 16678299
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Single nucleotide polymorphisms of HIV coreceptor CCR5 gene in Chinese Yi ethnic group and its association with HIV infection].
    Ma LY; Hong KX; Lu XZ; Qin GM; Chen JP; Chen KL; Ruan YH; Xing H; Zhu JH; Shao YM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3181-5. PubMed ID: 16405836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria.
    Ekere EF; Useh MF; Okoroiwu HU; Mirabeau TY
    BMC Infect Dis; 2020 Jan; 20(1):5. PubMed ID: 31900106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele.
    Galvani AP; Slatkin M
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15276-9. PubMed ID: 14645720
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is spatial distribution of the HIV-1-resistant CCR5Delta32 allele formed by ecological factors?
    Balanovsky O; Pocheshkhova E; Pshenichnov A; Solovieva D; Kuznetsova M; Voronko O; Churnosov M; Tegako O; Atramentova L; Lavryashina M; Evseeva I; Borinska S; Boldyreva M; Dubova N; Balanovska E
    J Physiol Anthropol Appl Human Sci; 2005 Jul; 24(4):375-82. PubMed ID: 16079584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCR5 genotypes and progression to HIV disease in perinatally infected children.
    de Angelis DS; Freire WS; Pannuti CS; Succi RC; Machado DM
    Braz J Infect Dis; 2007 Apr; 11(2):196-8. PubMed ID: 17625759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A mutated CCR5 gene may have favorable prognostic implications in MS.
    Kantor R; Bakhanashvili M; Achiron A
    Neurology; 2003 Jul; 61(2):238-40. PubMed ID: 12874407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
    Contopoulos-Ioannidis DG; O'Brien TR; Goedert JJ; Rosenberg PS; Ioannidis JP
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):70-6. PubMed ID: 12514416
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3'A variant in healthy individuals from different populations.
    Magierowska M; Lepage V; Boubnova L; Carcassi C; de Juan D; Djoulah S; El Chenawi F; Grunnet N; Hallé L; Ivanova R; Jungerman M; Naumova E; Petrany G; Sonnerborg A; Stavropoulos C; Thorsby E; Vu-Trieu A; Debré P; Theodorou I; Charron D
    Immunogenetics; 1998; 48(6):417-9. PubMed ID: 9799339
    [No Abstract]   [Full Text] [Related]  

  • 51. HIV and the CCR5-Delta32 resistance allele.
    de Silva E; Stumpf MP
    FEMS Microbiol Lett; 2004 Dec; 241(1):1-12. PubMed ID: 15556703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of new mutant sites of HIV-1 coreceptor CCR5 among Saudi populations.
    Abuelsaad AS; Al-Ghamdi AS; Al-Ghamdi AN; Alakkas EA; Alsulaimani AA; Al-Harthi AA; Abdel-Moneim AS
    J Interferon Cytokine Res; 2013 Dec; 33(12):783-9. PubMed ID: 23742258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary acute dengue and the deletion in chemokine receptor 5 (CCR5Δ32).
    Brestovac B; Halicki LA; Harris RP; Sampson I; Speers DJ; Mamotte C; Williams D
    Microbes Infect; 2014 Jun; 16(6):518-21. PubMed ID: 24607451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution of the CCR5 gene 32-bp deletion in Europe.
    Lucotte G; Mercier G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):174-7. PubMed ID: 9768627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
    Allers K; Schneider T
    Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A survey for 32 nucleotide deletion in the CCR-5 chemokine receptor gene (deltaccr-5) conferring resistance to human immunodeficiency virus type 1 in different ethnic groups and in chimpanzees.
    Voevodin A; Samilchuk E; Dashti S
    J Med Virol; 1998 Jun; 55(2):147-51. PubMed ID: 9598936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness.
    Wilkinson DA; Operskalski EA; Busch MP; Mosley JW; Koup RA
    J Infect Dis; 1998 Oct; 178(4):1163-6. PubMed ID: 9806051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of the CCR5 delta 32 mutant allele in HIV-1-positive patients, female sex workers, and a normal population in Taiwan.
    Li C; Yan YP; Shieh B; Lee CM; Lin RY; Chen YM
    J Formos Med Assoc; 1997 Dec; 96(12):979-84. PubMed ID: 9444918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.